Seqirus Pty Ltd
Melbourne, AU· latest recorded location
Seqirus Pty Ltd is named on 2 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 2
- Published applications
- 5
- Inventors
- 6
- Granted in 2026 so far
- 0
- Most recent grant
- 21 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
By publication year.
Technology areas
Share of 7 documents
- A61KMedicines and medical preparations5
- C12NMicroorganisms or enzymes5
- B01JChemical or physical processes4
- A61PTherapeutic uses of medicines2
- C07KPeptides2
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1
Recent patents
- Anti-sars-cov-2 antibodies and uses thereof ii31 Jul 2025US 2025/0244325 A1
- Anti-sars-cov-2 antibodies and uses thereof i5 Dec 2024US 2024/0400653 A1
- Removal of agglomerates5 Oct 2023US 2023/0310577 A1
- Method for producing reassortant influenza viruses5 Jan 2023US 2023/0000971 A1
- Removal of agglomerates2 Sep 2021US 2021/0268100 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.